Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low β-Arrestin Recruitment and Desensitization PotentialJohn Gatfield, Oliver Nayler|Journal of Pharmacology and Experimental Therapeutics|2017Cited by 35
S1P1 Modulator-Induced Gi Signaling and β-Arrestin Recruitment Are Both Necessary to Induce Rapid and Efficient Reduction of Blood Lymphocyte Count In VivoMagdalena Birker, Oliver Nayler|Molecular Pharmacology|2017Cited by 6